Regeneron Pharmaceuticals, Inc.
2013 Q4 - 2025 Q4 (27 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/13/2026 | 9,843 | 0.0% | 12,752 | 12/31/2025 |
| 2025 Q3 | 11/6/2025 | 4,711 | 0.0% | 8,379 | 9/30/2025 |
| 2025 Q2 | 8/12/2025 | 3,985 | 0.0% | 7,591 | 6/30/2025 |
| 2025 Q1 | 5/12/2025 | 8,914 | 0.0% | 14,055 | 3/31/2025 |
| 2024 Q4 | 2/14/2025 | 9,145 | 0.0% | 12,838 | 12/31/2024 |
| 2024 Q3 | 11/14/2024 | 4,563 | 0.0% | 4,341 | 9/30/2024 |
| 2024 Q2 | 8/14/2024 | 4,037 | 0.0% | 3,841 | 6/30/2024 |
| 2024 Q1 | 5/14/2024 | 2,081 | 0.0% | 2,162 | 3/31/2024 |
| 2023 Q4 | 2/14/2024 | 2,147 | 0.0% | 2,444 | 12/31/2023 |
| 2023 Q3 | 11/22/2023 | 9,410 | 0.1% | 11,434 | 9/30/2023 |
| 2023 Q2 | 8/14/2023 | 7,423 | 0.1% | 10,331 | 6/30/2023 |
| 2023 Q1 | 5/12/2023 | 9,719 | 0.1% | 11,828 | 3/31/2023 |
| 2022 Q4 | 2/14/2023 | 9,619 | 0.1% | 13,332 | 12/31/2022 |
| 2022 Q3 | 1/10/2023 | 7,915 | 0.1% | 11,490 | 9/30/2022 |
| 2022 Q2 | 8/12/2022 | 6,142 | 0.1% | 10,391 | 6/30/2022 |
| 2022 Q1 | 5/13/2022 | 10,457 | 0.1% | 14,973 | 3/31/2022 |
| 2021 Q4 | 2/14/2022 | 11,142 | 0.1% | 17,643 | 12/31/2021 |
| 2021 Q3 | 11/12/2021 | 10,726 | 0.1% | 17,723 | 9/30/2021 |
| 2021 Q2 | 8/13/2021 | 9,167 | 0.1% | 16,413 | 6/30/2021 |
| 2021 Q1 | 5/14/2021 | 4,709 | 0.0% | 9,953 | 3/31/2021 |
| 2020 Q4 | 2/12/2021 | 3,982 | 0.0% | 8,243 | 12/31/2020 |
| 2020 Q3 | 11/13/2020 | 7,072 | 0.1% | 12,633 | 9/30/2020 |
| 2020 Q2 | 8/14/2020 | 6,089 | 0.1% | 9,763 | 6/30/2020 |
| 2020 Q1 | 5/14/2020 | 3,888 | 0.0% | 7,963 | 3/31/2020 |
| 2019 Q4 | 2/14/2020 | 15,062 | 0.1% | 40,113 | 12/31/2019 |
| 2014 Q1 | 5/15/2014 | 8,648 | 0.1% | 28,800 | 3/31/2014 |
| 2013 Q4 | 2/11/2014 | 8,037 | 0.1% | 29,200 | 12/31/2013 |